TP53 and cancer: To clearly understand whether this weaker activity of p53 from LFS cells was characteristic of the unique genetic syndrome of LFS or a phenomenon shared by other human cancer cell lines, we utilized Jurkat cells (immortalized human T lymphocyte cells) to conduct more caspase activation assays.